Literature DB >> 28540665

Different Molecular Mechanisms Mediate Direct or Glia-Dependent Prion Protein Fragment 90-231 Neurotoxic Effects in Cerebellar Granule Neurons.

Stefano Thellung1, Elena Gatta2, Francesca Pellistri2, Valentina Villa1, Alessandro Corsaro1, Mario Nizzari1, Mauro Robello2, Tullio Florio3.   

Abstract

Glia over-stimulation associates with amyloid deposition contributing to the progression of central nervous system neurodegenerative disorders. Here we analyze the molecular mechanisms mediating microglia-dependent neurotoxicity induced by prion protein (PrP)90-231, an amyloidogenic polypeptide corresponding to the protease-resistant portion of the pathological prion protein scrapie (PrPSc). PrP90-231 neurotoxicity is enhanced by the presence of microglia within neuronal culture, and associated to a rapid neuronal [Ca++] i increase. Indeed, while in "pure" cerebellar granule neuron cultures, PrP90-231 causes a delayed intracellular Ca++ entry mediated by the activation of NMDA receptors; when neuron and glia are co-cultured, a transient increase of [Ca++] i occurs within seconds after treatment in both granule neurons and glial cells, then followed by a delayed and sustained [Ca++] i raise, associated with the induction of the expression of inducible nitric oxide synthase and phagocytic NADPH oxidase. [Ca++] i fast increase in neurons is dependent on the activation of multiple pathways since it is not only inhibited by the blockade of voltage-gated channel activity and NMDA receptors but also prevented by the inhibition of nitric oxide and PGE2 release from glial cells. Thus, Ca++ homeostasis alteration, directly induced by PrP90-231 in cerebellar granule cells, requires the activation of NMDA receptors, but is greatly enhanced by soluble molecules released by activated glia. In glia-enriched cerebellar granule cultures, the activation of inducible nitric oxide (iNOS) and NADPH oxidase represents the main mechanism of toxicity since their pharmacological inhibition prevented PrP90-231 neurotoxicity, whereas NMDA blockade by D(-)-2-amino-5-phosphonopentanoic acid is ineffective; conversely, in pure cerebellar granule cultures, NMDA blockade but not iNOS inhibition strongly reduced PrP90-231 neurotoxicity. These data indicate that amyloidogenic peptides induce neurotoxic signals via both direct neuron interaction and glia activation through different mechanisms responsible of calcium homeostasis disruption in neurons and potentiating each other: the activation of excitotoxic pathways via NMDA receptors and the release of radical species that establish an oxidative milieu.

Entities:  

Keywords:  Astrocytes; Microglia; NMDA; Neuronal death; Nitric oxide; Prion protein; [Ca++] i

Mesh:

Substances:

Year:  2017        PMID: 28540665     DOI: 10.1007/s12640-017-9749-2

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  92 in total

Review 1.  Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.

Authors:  Claudio Soto; Lisbell Estrada; Joaquín Castilla
Journal:  Trends Biochem Sci       Date:  2006-02-13       Impact factor: 13.807

2.  Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie.

Authors:  M E Bruce; P A McBride; C F Farquhar
Journal:  Neurosci Lett       Date:  1989-07-17       Impact factor: 3.046

Review 3.  Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo.

Authors:  D T Weldon; S D Rogers; J R Ghilardi; M P Finke; J P Cleary; E O'Hare; W P Esler; J E Maggio; P W Mantyh
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

Review 4.  Protein aggregation diseases: pathogenicity and therapeutic perspectives.

Authors:  Adriano Aguzzi; Tracy O'Connor
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

5.  In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.

Authors:  Joëlle Chabry; Christiane Ratsimanohatra; Isabelle Sponne; Pierre-Paul Elena; Jean-Pierre Vincent; Thierry Pillot
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

6.  Morphogenesis of amyloid plaques in 87V murine scrapie.

Authors:  M Jeffrey; C M Goodsir; M E Bruce; P A McBride; C Farquhar
Journal:  Neuropathol Appl Neurobiol       Date:  1994-12       Impact factor: 8.090

7.  Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes.

Authors:  Thomas Tousseyn; Krystyna Bajsarowicz; Henry Sánchez; Ania Gheyara; Abby Oehler; Michael Geschwind; Bernadette DeArmond; Stephen J DeArmond
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

Review 8.  Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease.

Authors:  Milan Fiala; David H Cribbs; Mark Rosenthal; George Bernard
Journal:  J Alzheimers Dis       Date:  2007-07       Impact factor: 4.472

9.  Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation.

Authors:  A Corsaro; S Thellung; V Villa; D Rossi Principe; D Paludi; S Arena; E Millo; D Schettini; G Damonte; A Aceto; G Schettini; T Florio
Journal:  Ann N Y Acad Sci       Date:  2003-12       Impact factor: 5.691

10.  Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures.

Authors:  Jeppe Falsig; Tiziana Sonati; Uli S Herrmann; Dino Saban; Bei Li; Karina Arroyo; Boris Ballmer; Pawel P Liberski; Adriano Aguzzi
Journal:  PLoS Pathog       Date:  2012-11-01       Impact factor: 6.823

View more
  3 in total

Review 1.  Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets.

Authors:  Stefano Thellung; Alessandro Corsaro; Irene Dellacasagrande; Mario Nizzari; Martina Zambito; Tullio Florio
Journal:  Front Neurosci       Date:  2022-09-06       Impact factor: 5.152

2.  Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death.

Authors:  Stefano Thellung; Beatrice Scoti; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Maria Cristina Gagliani; Carola Porcile; Claudio Russo; Aldo Pagano; Carlo Tacchetti; Katia Cortese; Tullio Florio
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

Review 3.  Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells.

Authors:  Stefano Thellung; Alessandro Corsaro; Alessia G Bosio; Martina Zambito; Federica Barbieri; Michele Mazzanti; Tullio Florio
Journal:  Cells       Date:  2019-11-18       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.